Acquisition by Mathiesen Jeffrey S of 2693000 shares of Helius Medical subject to Rule 16b-3

HSDT Stock  USD 0.49  0.03  6.52%   
Slightly above 71 percent of all Helius Medical's private investors are curious in acquiring. The analysis of overall sentiment of trading Helius Medical Technologies stock suggests that a large number of investors are confidant at this time. Helius Medical's investing sentiment can be driven by a variety of factors including economic data, Helius Medical's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Helius Medical Technologi director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Helius insider trading alert for grant of stock option right to buy by Mathiesen Jeffrey S, CFO and Treasurer, on 16th of February 2023. This event was filed by Helius Medical Technologi with SEC on 2023-02-16. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Helius Medical's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Helius Medical's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Helius Medical Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Helius Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Helius Medical Fundamental Analysis

We analyze Helius Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Helius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Helius Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Helius Medical is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Helius Medical Techn Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Helius Medical stock to make a market-neutral strategy. Peer analysis of Helius Medical could also be used in its relative valuation, which is a method of valuing Helius Medical by comparing valuation metrics with similar companies.

Peers

Helius Medical Related Equities

NUWENuwellis   19.66   
0%
68.0%
VVOSVivos Therapeutics   4.14   
0%
14.0%
TIVCTivic Health   4.00   
0%
13.0%
HSCSHeart Test   3.62   
0%
12.0%
SSKNSTRATA Skin   0.68   
0%
2.0%
SGHTSight Sciences   0.75   
2.0%
0%
BBLGBone Biologics   0.76   
2.0%
0%
RSLSReShape Lifesciences   1.22   
4.0%
0%
ASAPFAurora Spine   3.13   
10.0%
0%
BJDXBluejay Diagnostics   3.47   
12.0%
0%
RPIDRapid Micro   4.55   
15.0%
0%
SINTSINTX Technologies   28.71   
100.0%
0%

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.